Jamie Christensen, SVP, Chief Science Officer at Mirati Therapeutics, Inc. (MRTX), sold 14,725 shares at $23.00 ($338K) on 2018-01-11, disclosed to the SEC on 2018-01-11.
Open-market sale of $338k MRTX by SVP, Chief Science Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.00 | 225 | $5K | 1.5% |
| 2 | $23.00 | 14,500 | $334K | 98.5% |
| Total | $22.98 avg | 14,725 | $338K | 100% |
| Filing → |
| MRTX | SELL | 2023-12-19 | $275K | — | Filing → |
| MRTX | SELL | 2023-09-12 | $170K | — | Filing → |
| MRTX | SELL | 2023-05-24 | $28K | — | Filing → |